Accumulating evidence in animal models and human cancer tissues show that the Fas/FasL pathway can be exploited by immune cells and tumor cells, exhibiting both antitumor and tumor-promoting effects; however, very limited data exist on the role of this pathway in the periphery. Here, FAS is linked to cancer.